Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Reasons for late diagnostics of lung cancer in pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012
Causes of therapeutical failure in tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 42s Year: 2003
The reasons of unfavorable outcomes of treatment in pulmonary tuberculosis patients in Kyrgyzstan Source: Eur Respir J 2004; 24: Suppl. 48, 648s Year: 2004
Reasons of malnutrition development in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 163s Year: 2006
Relapse and failure pulmonary tuberculosis patients have the chance of cure with major antituberculosis drugs Source: Eur Respir J 2007; 30: Suppl. 51, 657s Year: 2007
Pathogenetic methods of treatment for pulmonary TB in adolescents Source: Eur Respir J 2002; 20: Suppl. 38, 369s Year: 2002
The assessment of risk factors and treatment of pulmonary TB relapses Source: Eur Respir J 2006; 28: Suppl. 50, 129s Year: 2006
Effectiveness of treatment and correction of side effects in pulmonary MDR/XDR TB patients with concomitant liver injury Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017
Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector Year: 2007
Reasons why pulmonary pressure increases in COPD patients Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001
Specific features of acute renal failure in rifampicin treated patients for pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 609s Year: 2002
Optimising pharmacotherapy in patients with pulmonary arterial hypertension and comorbidities, including lung diseases and heart failure: benefits without harm? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018
Perspectives on antibiotic treatment of NTM pulmonary disease Source: Eur Respir Monogr 2017; 75: 245-252 Year: 2017
Causes of delay in the diagnosis of pulmonary tuberculosis Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
On the efficiency of the long-term hospitalization treatment of patients with social problems with severe pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 369s Year: 2002
Monitoring of new pulmonary TB patients: detection and treatment Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009
Heart rate variability: Possible implications for management of pulmonary arterial hypertension patients Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012